Geron Q4 Earnings Call Highlights [Yahoo! Finance]
Geron Corporation (GERN)
Last geron corporation earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
geron.com/investors
Company Research
Source: Yahoo! Finance
Geron (NASDAQ:GERN) management used its fourth-quarter 2025 earnings call to outline how strategic alignment work completed in 2025 is expected to support RYTELO demand growth in 2026 while lowering the company's expense base following a December restructuring. RYTELO results and 2026 outlook Chief Executive Officer Harout Semerjian said RYTELO net revenue in the fourth quarter was $48 million , which he described as in line with expectations. For the full year 2025, Geron reported $184 million in RYTELO net revenue, which Semerjian called “a meaningful number for a hematology drug in its first full commercial year.” ? Hinge Health's AI Moat Might Be Its Patient Movement Data Geron Stock Doubles After Imetelstat Receives FDA Panel Approval For 2026, the company guided to RYTELO net revenue of $220 million to $240 million , with an assumption of consistent quarter-over-quarter demand growth. Chief Financial Officer Michelle Robertson added that Geron expects “a greater porti
Show less
Read more
Impact Snapshot
Event Time:
GERN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GERN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GERN alerts
High impacting Geron Corporation news events
Weekly update
A roundup of the hottest topics
GERN
News
- Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B MilestonePR Newswire
- Is Geron (GERN) Using Its New ATM Program To Prioritize Flexibility Over Shareholder Dilution? [Yahoo! Finance]Yahoo! Finance
- Geron Corp (GERN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments [Yahoo! Finance]Yahoo! Finance
- Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
GERN
Earnings
- 2/25/26 - Miss
GERN
Sec Filings
- 3/3/26 - Form SCHEDULE
- 3/2/26 - Form S-3ASR
- 3/2/26 - Form 10-K
- GERN's page on the SEC website